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Benzene Induces a Dose-responsive Increase
in the Frequency of Micronucleated Cells
in Rat Zymbal Glands
Frank A. Angelosanto, Gary R. Blackburn, Ceinwen A.
Schreiner, and Carl R. Mackerer
Stonybrook Laboratories Inc., Princeton, New Jersey
The Zymbal gland, a sebaceous tissue associated with the ear duct of certain rodent species, is a
principal target for carcinogenesis by benzene. To investigate the mechanism of induction of
tumors in the rat Zymbal gland, we have developed a procedure for primary culture of epithelial
cells from Zymbal gland explants so that cytogenetic analysis can be performed on this target
tissue following an in vivo exposure to benzene. Cytogenetic analysis performed 45 hr after in
vivo oral dosing with benzene revealed chromosome damage that occurred as a result of acute,
subchronic, and chronic dosing. This damage, expressed as a dose-related increase in the
frequency of micronucleated cells, was observed in Sprague-Dawley female rats over a range of
benzene doses from 12.5 to 250 mg/kg/day, and in male Fischer 344 rats at doses ranging from 1
to 200 mg/kg/day. These results are consistent with the known clastogenicity of benzene in
mouse bone marrow, which is also a target tissue. This study is the first report of a genotoxic
effect of benzene in the rat Zymbal gland and shows that micronucleus formation may be used
as a correlate for carcinogenesis induced by benzene in this target tissue. Environ Health
Perspect 104(Suppl 6):1331-1336 (1996)
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Introduction
The biological effects of exposure to the
aromatic hydrocarbon benzene have been
studied in human and animal models.
Human epidemiological studies have impli-
cated benzene as a potential myelotoxic and
leukemogenic agent for workers exposed to
high levels (1-3). Other toxic effects of
benzene exposure in humans are bone
marrow hypoplasia and aplasia. Also, an
increased level ofchromosome damage in
lymphocytes has been reported for humans
exposed to benzene (4,5). Mechanistic
studies have shown that benzene is not the
actual toxic species but must be metabo-
lized in order to exert its carcinogenic and
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toxic effects (6-9). The major metabolism
ofbenzene in vivo takes place in the liver,
and the main metabolites are phenol,
hydroquinone, catechol, 1,2,4-benzenetriol,
and trans-trans-muconic acid (10-12). The
phenolic metabolites may then be oxidized
to highly reactive quinones by peroxidase
enzymes present in target tissues (13-15).
However, the metabolite(s) responsible for
the leukemia attributable to benzene has
not been determined.
Extensive in vitro tests have indicated
that benzene is weakly mutagenic or non-
mutagenic in standard mutation assays
(16,17) but does cause chromosome aber-
rations (16-18) and induces sister chro-
matid exchanges (SCEs) (16,19) under
appropriate assay conditions, although at a
substantially reduced level compared to
benzene metabolites. Numerous in vivo
cytogenetic studies have demonstrated that
benzene exposure causes structural chro-
mosome aberrations (20,21), induces
micronuclei formation (22), and increases
the frequency of SCEs in bone marrow
cells of mice or rats (23,24). The benzene
metabolite hydroquinone has been shown
to induce chromosome aberrations and
micronuclei in bone marrow cells ofmice,
and the micronuclei result from both
clastogenicity and a spindle impairment
mechanism (25,26).
Although animal studies have shown
that benzene exposure causes chromosome
changes in bone marrow cells, and leukemia
in humans is associated with chromosome
abnormalities (27), no convenient animal
model for benzene-induced leukemia exists
(2,3). However, benzene induces a dose-
dependent formation ofsolid tumors in var-
ious tissues. Large-scale, chronic exposure
studies by Maltoni et al. (28) performed on
rats using inhalation or oral administration
of benzene resulted in the appearance of
tumors ofthe Zymbal glands, specialized
sebaceous glands located in the region ofthe
external ear canal ofrodents (29,30), and at
other sites including oral and nasal cavities
and liver (28). The finding of Zymbal
gland tumors was confirmed in a National
Toxicology Program (NTP) study oforally
treated rats and mice (20,31).
Because ofthe relatively high incidence
oftumors induced in Zymbal glands in the
Maltoni (28) and NTP (31) studies, we
chose this target tissue for our study ofthe
genotoxic effects ofbenzene. The Zymbal
gland possesses both cytochrome P450 (32)
and peroxidase (33) activities and is a target
for tumor formation by several classes of
carcinogens, including aromatic amines and
polycyclic aromatics (29,34).
Although the chronic oncogenicity
studies using high exposure levels clearly
indicated dose-responsive induction of
Zymbal gland tumors by benzene (28,31),
they could not provide information on
tumor formation at very low-level expo-
sures because of the prohibitively large
number ofanimals needed for such studies.
The identification of a genotoxicity end
point in the Zymbal gland that would
serve as a dose-response correlate for car-
cinogenicity in that tissue could provide an
estimate ofexpected carcinogenicity at low
levels ofbenzene exposure. Ifthe genotox-
icity response at low doses departed from a
linear dose response based on high concen-
tration effects, a case could be made for an
analogous departure from linearity in the
dose-response curve for tumor formation.
The small size ofthe Zymbal gland and
the limited mitotic activity present in the
gland (30) make it difficult to perform
genotoxicity assays on direct preparations
of this tissue. The present study describes
the development of a method for measur-
ing chromosome damage, as evidenced by
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micronuclei formation, in Zymbal gland
cells ofrats exposed to benzene.
Micronuclei result from acentric chro-
mosomal fragments orwhole chromosomes
that are not incorporated into daughter
nuclei during cell division, and are indica-
tors ofchromosome breakage or damage to
the spindle apparatus. Since completion of
mitosis is necessary for micronucleus for-
mation, a micronucleus assay must ensure
that cell division has occurred during or
after exposure to the test material and
before cell fixation.
The protocol used in this study
involves an in vivo exposure to benzene,
explant culture ofZymbal gland cells, and
analysis for micronuclei in cells that have
undergone one or more post-treatment
mitoses. Similar methodologies have been
used to detect chromosome damage after
an in vivo exposure to a suspected xenobi-
otic agent in short-term cultures ofhuman
(35,36) or rodent blood lymphocytes
(37,38), mouse skin keratinocytes (39),
and rodent lung cells (40).
Using the Zymbal gland cell micro-
nucleus assay, we determined the dose-
response relationship between benzene
exposure and chromosome damage in
Zymbal glands ofrats treated at dose ranges
similar to those used in the oncogenicity
studies as well as at lower exposure levels.
Methods
Animals andDosing
Female Sprague-Dawley rats, Crl:
CD(SD)BR, obtained from Charles
Laboratories (Wilmington, MA) were
approximately 16 weeks of age at time of
dosing. Male Fischer rats, F344/NTacfBR,
obtained from Taconic Laboratory Animals
and Services (Germantown, NY) were
approximately 9 weeks of age. The rats
were housed individually in stainless steel
wire cages, and were maintained at 19 to
22°C with a 12-hr day-night lighting cycle.
Purina Lab Chow and water were provided
adlibitum.
Solutions ofbenzene (American Burdick
andJackson, Muskegon, MI) were prepared
in olive oil (Sigma Chemical Co., St.
Louis, MO). Rats were weighed on the first
day ofdosing and were dosed by oral gav-
age at the rate of3 ml/kg bw. Control rats
were gavaged with olive oil only at the
same rate. Dosing occurred once a day in
the morning on 3 consecutive days unless
stated otherwise. Animals were sacrificed
approximately 24 hr after delivery of the
last dose.
PreianngZymbal Glandsfor
Cell Culture
Rats were killed by CO2 asphyxiation.
Sterile instruments were used, and the sur-
face ofeach animal was washed with anti-
septic and ethanol before making an initial
incision. A skin incision was made below
the ear and pulled open to expose the ear
canal and jaw muscle. Two prominent ten-
dons below the ear were cut, exposing the
Zymbal gland. The gland was held by for-
ceps and excised using a scalpel. Both
Zymbal glands were removed from each rat.
The glands were placed in sterile, ice-chilled
LI5 medium until they were processed for
cell culture. All media and solutions used to
prepare and culture the Zymbal glands were
sterile, and aseptic techniques were routine.
The excised glands were washed with
Ham's F12 medium, minced. and placed
in 15 ml ofa digestion solution consisting
of 0.5% (w/v) collagenase type I, 0.3%
(w/v) hyaluronidase, 50 pg/ml gentamicin,
1.5 pg/ml amphotericin B, and 0.5% fetal
bovine serum in Ham's F12 medium. The
minced glands were treated overnight at
37°C on a rotary apparatus, which resulted
in the digestion of adhering connective
tissue and removed stromal cells from the
gland pieces. The glandular fragments were
collected onto a 53-mm mesh nylon screen
by gravity filtration. They were washed
with Hank's balanced salt solution (HBSS),
followed by a small volume (1-2 ml) ofthe
culture medium. The fragments were
removed from the screen with a pipette
using a minimal volume of medium and
placed on the surface of a coated coverslip
in a multiwell plate. Approximately 2 ml of
culture medium was added to the wells,
and the plates were placed in a humidified
incubator at 37°C with an atmosphere of
5% CO2 in air.
The enzymatic digestion procedure,
described above and used by Stampfer (41)
to obtain pure epithelial cell cultures from
human mammary tissues, was used to
remove stromal cells and connective tissue
components from the glandular portion of
the Zymbal tissue. The inclusion of this
step eliminated the contamination of
fibroblastlike cells from the cultures and
also improved the rate ofsuccess for initiat-
ing cellular outgrowths from the attached
explant material.
GrowthSurfaePreparation
Because many epithelial cells display
enhanced growth on surfaces coated with
components of the basement membrane,
we precoated the growth surfaces with
collagen and fibronectin using a method
developed by Lechner and LaVeck (42)
for culturing bronchial epithelial cells.
Thermanox plastic tissue culture coverslips
(Lux #5412, 24x30 mm) were placed in
the wells ofan eight-well tissue culture plate
(Lux #5218, 26x33 mm) and were coated
with a solution containing a mixture of
fibronectin (10 pg/ml), collagen (Vitrogen
100; 60 pg/mi) and bovine serum albumin
(0.1 mg/ml) dissolved in Ham's F12
medium. Approximately 1.5 ml ofthe solu-
tion was added to each well. The multiwell
plates were incubated for at least 2 hr at
370C. The coating solution was removed
from the wells by vacuum aspiration, and
the coverslips were washed with culture
medium before seeding tissue explants for
culture initiation.
Cell Culture
Culture medium consisted ofMCDB 201
base (Sigma Chemical Co.) supplemented
with 5 pg/ml insulin, 10 ng/ml epidermal
growth factor (EGF), 1.4 pg/ml hydrocor-
tisone, 20 pg/ml transferrin, 70 fig/ml
bovine pituitary extract (43), 0.5 pM phos-
phoethanolamine, 0.5 pM ethanolamine,
6.5 ng/ml triiodothyronine, 0.1 pg/ml
retinoic acid, 0.5 mM sodium pyruvate, 2
mM L-glutamine, 50 pg/ml gentamicin,
and 1.5 pg/ml amphotericin B. The
medium was also supplemented with a
trace elements solution (42) obtained from
Biofluids Inc. (Rockville, MD) so that the
culture medium contained 1 nM nickel, 1
nM molybdenum, 30 nM selenium, 5 nM
vanadium, 0.5 nM tin, and 0.5 pM silicon.
Stock solutions for additives to the base
medium were prepared as described by
Lechner and LaVeck (42). Source ofmedia
components and enzymes was Sigma
Chemical Co. unless otherwise noted.
A serum-free medium was chosen
because our preliminary attempts to obtain
cell outgrowths from Zymbal gland tissue
explants using fetal bovine supplemented
media proved unsuccessful. The serum-free
growth medium selected for use in the
experiments described in the present study
differs only slightly from MCDB 170
medium, which was developed for serum-
free culture ofhuman mammary epithelial
cells (44). Medium MCDB 170 also pro-
vides good growth for Zymbal gland cells
using the explant technique.
Description ofCells inOutgrowths
inSerum-freeMedium
Ofthe explanted Zymbal tissue thatattached
to the growth surface, cell migration from
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the explants was observed as early as 6 hr
after plating. After 20 hr in culture, the
beginning ofa monolayer ofepithelial cells
was seen radiating from the explanted tissue
that had successfully attached, with some
mitotic cells present at this time. After 45 hr
in culture, a monolayer of epithelial-like
cells, ranging from about 500 to 3000 cells,
appeared around the explants that attached,
with many mitotic cells clearly visible
using low power magnification. If main-
tained in culture, the monolayers continued
to expand, and confluent cultures have been
obtained after several more days in culture
without the appearance offibroblasdike cells.
Staining of a representative primary
culture with Oil Red stain (45) after 96 hr
in culture resulted in a strong staining reac-
tion in the remaining explanted material,
indicating that the monolayer ofepithelial
cells had grown out of a lipid-rich tissue,
consistent with Zymbal gland as the source
for the monolayer ofcells. Adding colcemid
after 40 hr in culture and fixing cells in situ
4 hr later resulted in the finding that 20%
ofthe cells were at the metaphase stage of
mitosis, indicating that a large proportion
ofthe cells in the monolayer were actively
dividing at that time.
CellFixationand Staining
The fixation procedure was performed in
situ on the coverslips so that all the cell out-
growths were available for analysis. After
approximately 45 hr of incubation, the
medium was removed, the coverslips were
washed with HBSS, and approximately 2 ml
ofCa2+, Mg2+-free HBSS containing trypsin
(0.2 mg/ml), EGTA (0.2 mg/ml), and
polyvinylpyrrolidine (10 mg/ml) were
added to each well, which caused the cells
to separate slightly from each other but
remain attached to the coverslip. After
approximately 5 min, the solution was
removed and replaced with an equal vol-
ume of0.075 M KCl. After 1 min, 0.5 ml
offixative (methanol:acetic acid, 3:1, v/v)
was added to each well. The liquid was
then removed and replaced with about 2 ml
of fixative. The fixative was added and
removed 2 more times, after which the cov-
erslips were air dried. The coverslips were
stained with 4% Giemsa in H20 for 10
min and dried. The coverslips were placed
sequentially in acetone, then acetone:xylene
(1:1), and finally xylene before being
mountedwith Permount onto aglass slide.
AnalysisforMicronudeatedCells
Cells were scanned for the presence of
micronuclei by microscopic examination
using a 400x objective lens and analyzed
using a 630x objective lens. Only cells in
the monolayer outgrowths from the
explants were analyzed. A body was scored
as a micronucleus by meeting the following
criteria: a) color intensity similar to main
nucleus; b) diameter between 1/20 and 1/4
that ofthe main nucleus; c) resides within
the cytoplasm; d) roundish in shape with
distinctly recognizable border; and e) com-
pletely separable from main nucleus and not
a nuclear bleb. Degenerating cells with
nuclear fragmentation were excluded from
evaluation. A minimum of 1000 cells per
animal were scored for the presence of
micronuclei except where noted. Frequency
of micronucleated cells is expressed as
micronucleated cells per 1000 cells analyzed.
Results
The Zymbal gland primary cell culture
method was used to determine ifan in vivo
exposure to benzene would result in an
increased level of cytogenetic damage in
cells growing out of the Zymbal tissue
explants. Because cytogenetic damage can
be "diluted-out" after the first or second
cell division, a fixation time of 45 hr in
culture was chosen. This time allows a
sufficient number ofcells to migrate out of
the explants and be amenable for cytoge-
netic analysis but restricts these cells to two
cell divisions after excision. Initially, we
attempted to analyze for structural chromo-
some aberrations in colcemid-arrested
metaphase cells, but we found it difficult to
locate sufficient good quality cells for defin-
itive analysis. However, we did notice that
some of the cells contained micronuclear
bodies, and since an assay for micronucleus
induction is not limited to metaphase cells,
we decided to use this cytogenetic end
point rather than structural chromosome
aberrations as the indicator of benzene-
induced genetic damage.
In the initial evaluation of the test
system, the explant culture technique was
used to determine if a single in vivo
exposure to a high dose ofbenzene would
increase the frequency of micronucleated
cells in the initial monolayer outgrowth
from cultured Zymbal gland tissue. A sin-
gle oral dose ofbenzene, 1000 mg/kg, was
delivered to two Sprague-Dawley female
rats, Zymbal glands were removed 24 hr
later, cultured for 45 hr, and evaluated for
the frequency ofmicronucleated cells. The
results are presented in Table 1 and show
that a higher frequency of micronucleated
cells was present in the benzene-treated rats
than in olive oil-treated control rats. A sec-
ond experiment was performed in which
female Sprague-Dawley rats were dosed
orally with 250 mg/kg/day benzene on 3
consecutive days. Zymbal glands were
removed approximately 24 hr after the last
dose, cultured, and analyzed for micronu-
cleated cells. As shown in Table 1, again, a
higher frequency of micronucleated cells
was found after benzene exposure com-
pared to vehicle controls.
Assays were also conducted on chroni-
cally treated rats. Sprague-Dawley female
rats were dosed orally with 250, 25, and
1.5 mg/kg/day benzene or with olive oil
only, once a day, 5 days per week for 26
weeks. Zymbal glands were excised from
one rat in each dose group. The results of
the micronucleus assay are shown in Table
2. Zymbal gland cells from the benzene-
treated animals had an elevated frequency
of micronuclei compared to those of the
control animals, although at the lowest
dose, 1.5 mg/kg, the increase was statisti-
cally significant only at the p=0.054 level
(normal test, one-tail).
Having established that in vivo benzene
treatment produces an elevated incidence of
micronucleated cells in cultures ofZymbal
gland tissues, we designed an experiment to
determine the nature of the dose response
for this induction. Two Sprague-Dawley
female rats per dose group were treated on
3 consecutive days, and the dose range
Table 1. Frequency of micronucleated cells in 45-hr Zymbal gland explant cell cultures from female Sprague-
Dawley rats.
Frequency of
No. of No. of cells No. of micronucleated
Treatment animals analyzed micronucleated cells cells/1000
Single dose experiment
Benzene, 1000 mg/kg 2 2852 102 36
Olive oil, vehicle control 2 4079 42 10
Three daily dose experiment
Benzene, 250 mg/kg/day 2 3128 57 18
Olive oil, vehicle control 2 1845a 10 5
aOne ofthe animals had less than 1000 cells analyzed.
Environmental Health Perspectives * Vol 104, Supplement 6 * December 1996 1 333ANGELOSANTO ETAL.
Table 2. Frequency of micronucleated cells in 45-hr Zymbal gland cell explant cultures from female Sprague-
Dawley rats treated 5 days perweek for 26 weeks (single animal/dose).
No. ofcells No. of Frequency of
Treatment analyzed micronucleated cells micronucleated cells/1000
Benzene, 250 mg/kg/day 2013 40 20**
Benzene, 25 mg/kg/day 2035 40 20**
Benzene, 1.5 mg/kg/day 2024 17 8*
Olive oil, vehicle control 2053 9 4
** p< 0.001 (normal test, one-sided); *p = 0.054(normal test, one-sided).
covered 0 to 200 mg/kg/day. The results of
this micronucleus experiment are shown in
Figure 1 and indicate that a dose-respon-
sive increase in the frequency ofmicronu-
cleated cells occurred over this dose range.
Figure 1 also displays data from the onco-
genicity study ofMaltoni et al. (28) for the
incidence of Zymbal gland tumors in
female Sprague-Dawley rats in the 250, 50,
and 0 mg/kg/day benzene dose groups.
The nature ofthe dose response was also
examined in male rats using the strain
(Fischer 344/N) used in the NTP carcino-
genesis study ofbenzene (17,31). Two rats
per dose group were administered oral
doses of benzene ranging from 0 to 200
mg/kg/day on 3 consecutive days. The
results of the micronucleus analysis are
shown in Figure 2. A dose-responsive
increase was again seen. The assay was
repeated at doses of 1 and 10 mg
benzene/kg/day to determine if the sensi-
tivity of the method is sufficient to detect
differences in the responses between these
doses and a vehicle control (olive oil-only
treatment). The results of this assay are
presented in Table 3 and indicate that a
statistically significant difference was
found between the 10 mg/kg/day dose
o
.
group and the vehicle control but not
between the 1 mg/kg/day and the vehicle
control groups.
Discussion
The development ofa method for obtain-
ing primary cultures of rat Zymbal gland
cells has made it possible to measure the
genotoxic effects of an in vivo benzene
exposure in a tissue known to develop solid
tumors as a result ofchronic exposure to
this chemical under laboratory conditions.
In developing the methodology, the choice
ofa growth medium was crucial to its suc-
cess, and in the case of rat Zymbal gland
cells, a serum-free medium was necessary
for good cell growth. The growth medium
that was developed is similar in composi-
tion to MCDB 170, a medium that was
developed for culturing epithelial cells of
the mammary gland (41,44) which, at
least superficially, the Zymbal gland resem-
bles. In developing the Zymbal gland
growth medium, the absolute requirement
ofeach component in the growth medium
for cell growth was not established, nor
were optimal concentrations ofeach ofthe
components determined. However, the
medium and culture conditions were
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Figure 1. Dose response for micronucleus formation
(solid squares) in Zymbal gland cells from female
Sprague-Dawley rats after three daily oral administra-
tions of benzene. Each square is an average for two
animals. At least 1000 cells were analyzed per animal.
Also shown (open circles) is the percentage of female
Sprague-Dawley rats bearing Zymbal gland carcinomas
after chronic exposure to doses of benzene reported by
Maltoni et al. (28).
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Figure 2. Dose response for micronucleus formation
(solid squares) in Zymbal gland cells from male Fischer
344 rats after three daily oral administrations of ben-
zene. Each square is an average for two animals. At
least 1000 cells were analyzed per animal. Also shown
(open circles) is the percentage of male Fischer 344
rats bearing Zymbal gland carcinomas after chronic
exposure to doses of benzene from the report of NTP
study(31).
Table 3. Frequency of micronucleated Zymbal gland
cells from male Fischer rats dosed with benzene.
Mean frequency
Frequency of of micronucleated
Daily dose of micronucleated cells/1000
benzene cells/1000 for dose group
100 mg/kg/day 29 28
26
27
29
10 mg/kg/day 19 18
20
17
18
17
1 mg/kg/day 8 9
10
9
8
9
0 mg/kg/day 9 9
8
7
11
9
shown to be adequate for the purpose of
providing a population ofearly dividing
cells from Zymbal gland tissue oftreated
rats so that the micronucleus assay could
be performed.
Because of the high frequency of
mitotic cells observed in the monolayers
fixed after 45 hr in culture, a cytokinesis-
block step using cytochalasin B was not
needed to identify dividing cells, although
this step was used in the micronucleus
assays developed for lymphocytes (36),
mouse skin keratinocytes (39), and Chinese
hamster lung fibroblasts (40).
It is generally desirable in a micronu-
cleus assay to examine cells that have under-
gone only one cell division during the
period between chemical exposure and cell
fixation. The cells in our experiments may
not have been restricted to one division but
probably underwent no more than two
divisions after placement in culture. This
conclusion is based on the observation that
the majority of cells forming the out-
growths appeared in the monolayer during
the 24 hr before fixation. The sensitivity of
the Zymbal gland micronucleus assay might
be improved by modifications to limit the
analysis to only cells that have completed
one division in culture. However, the assay,
as performed in the study, provided suffi-
cient sensitivity to detect a response from
high and low benzene exposures and from
cyclophosphamide (data not presented), a
known dastogen.
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The findings in this study of an
increased frequency ofmicronucleated cells
proliferating from Zymbal glands of rats
treated with single or multiple doses of
benzene is, to our knowledge, the first
report of a genotoxic effect in this target
tissue by in vivo exposure to benzene or
any other xenobiotic. Reddy et al. (30)
have reported that DNA adducts are
formed in this organ following an in vitro
but not an in vivoexposure to benzene.
The data from the present experiments
show a consistent induction ofmicronuclei
following either a single dose, three consec-
utive daily doses, or chronic (26 weeks)
dosing with benzene. Sprague-Dawley
female and Fischer male F344/N rats, both
susceptible to Zymbal gland carcinogene-
sis, appear to be equally susceptible to
micronucleus induction in this tissue. The
near linear induction of micronuclei over
the dose range of 12.5 to 200 mg/kg/day
dose response observed in female Sprague-
Dawley rats was similar to the pattern for
tumor induction (28).
In the case ofthe male Fischer F344/N
rats, the micronucleus induction pattern
appeared nonlinear, with a greater slope at
the lower concentrations, whereas the
tumor response seen in the NTP study was
linear (20,31). Because only two rats were
used per dose level in the micronucleus
assay, the observed differences may not be
significant. However, in the range from 50
to 200 mg/kg/day, the induction patterns
in both female and males are similar. Based
on the data acquired in this study of
Zymbal glands, the dose-response curve
for micronucleus induction follows a pat-
tern of decline with decreasing benzene
dose, similar to the response for carcino-
genesis. The data obtained in our study
with male Fischer F344/N rats indicate
that the micronucleus end point has suffi-
cient sensitivity to investigate a dose
response for benzene in rats at or below the
10 mg/kg/day level in Zymbal gland cells.
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